Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A molecularly integrated grade for meningioma
Joseph Driver, Samantha E. Hoffman, Sherwin Tavakol, et al.
Neuro-Oncology (2021) Vol. 24, Iss. 5, pp. 796-808
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Glioblastoma and Other Primary Brain Malignancies in Adults
Lauren Schaff, Ingo K. Mellinghoff
JAMA (2023) Vol. 329, Iss. 7, pp. 574-574
Closed Access | Times Cited: 520
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
Craig Horbinski, Tamar Berger, Roger J. Packer, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 9, pp. 515-529
Closed Access | Times Cited: 188
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
William Chen, Abrar Choudhury, Mark W. Youngblood, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3067-3076
Open Access | Times Cited: 54
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 28
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Justin Z. Wang, Vikas Patil, Alexander Landry, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3173-3183
Open Access | Times Cited: 16
Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies
James C. Bayley, Caroline Hadley, Arif Harmanci, et al.
Science Advances (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 62
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Abrar Choudhury, William Chen, Calixto‐Hope G. Lucas, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 3, pp. 520-530
Open Access | Times Cited: 40
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
Justin Z. Wang, Vikas Patil, Jeff Liu, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 1, pp. 145-162
Open Access | Times Cited: 24
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto‐Hope G. Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Nature Genetics (2024) Vol. 56, Iss. 6, pp. 1121-1133
Open Access | Times Cited: 15
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 2, pp. 319-330
Open Access | Times Cited: 12
Radiotherapy for meningiomas
William Chen, Haley K. Perlow, Abrar Choudhury, et al.
Journal of Neuro-Oncology (2022) Vol. 160, Iss. 2, pp. 505-515
Open Access | Times Cited: 30
Genomic markers of recurrence risk in atypical meningioma following gross total resection
Rachael A. Vaubel, Rahul Kumar, Taylor M. Weiskittel, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 18
Radiotherapy and radiosurgery for meningiomas
William Chen, Calixto‐Hope G. Lucas, Stephen T. Magill, et al.
Neuro-Oncology Advances (2023) Vol. 5, Iss. Supplement_1, pp. i67-i83
Open Access | Times Cited: 18
Dose-Escalated Radiation Therapy Is Associated With Improved Outcomes for High-Grade Meningioma
Kang Zeng, Hany Soliman, Sten Myrehaug, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 118, Iss. 3, pp. 662-671
Closed Access | Times Cited: 18
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas
Vivian Tang, Rufei Lu, Kanish Mirchia, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 497-500
Open Access | Times Cited: 17
Molecular classification and grading of meningioma
MacLean P. Nasrallah, Kenneth Aldape
Journal of Neuro-Oncology (2023) Vol. 161, Iss. 2, pp. 373-381
Closed Access | Times Cited: 17
Spinal Meningiomas: A Comprehensive Review and Update on Advancements in Molecular Characterization, Diagnostics, Surgical Approach and Technology, and Alternative Therapies
Danielle Dang, Luke Mugge, Omar Awan, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1426-1426
Open Access | Times Cited: 8
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy
Abrar Choudhury, Martha A. Cady, Calixto‐Hope G. Lucas, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1823-1837
Closed Access | Times Cited: 8
Artificial intelligence applications to genomic data in cancer research: a review of recent trends and emerging areas
Maria Frasca, Davide La Torre, Marco Repetto, et al.
Discover Analytics (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 6
EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6
Surgical strategies for intracranial meningioma in the molecular era
Alper Dincer, Saul F. Morales-Valero, Stephanie M. Robert, et al.
Journal of Neuro-Oncology (2023) Vol. 162, Iss. 2, pp. 253-265
Open Access | Times Cited: 16
WHO grade and pathological markers of meningiomas: Clinical and prognostic role
Raduan Ahmed Franca, Rosa Della Monica, Sergio Corvino, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154340-154340
Closed Access | Times Cited: 15
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042
Sybren L. N. Maas, Philipp Sievers, Damien C. Weber, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 6, pp. 837-840
Open Access | Times Cited: 14
CDKN2A/B deletions are strongly associated with meningioma progression: a meta-analysis of individual patient data
Johannes Wach, Alim Emre Basaran, Felix Arlt, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA‐Seq
Meng Huang, Shao Xu, Yuzhe Li, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top